Downtown Phoenix Inc. Selected for Community Beautification Project as APS Celebrates 140 Years in Arizona
PHOENIX–(BUSINESS WIRE)–#aps140–Downtown Phoenix Inc. (DPI) announced that it has been named a recipient of Arizona Public Service (APS) community... Read more.
Rachel Lanier Named to Law360’s List of Rising Stars for Her Trial Practice
LOS ANGELES–(BUSINESS WIRE)–Rachel Lanier, Managing Attorney of the Los Angeles office for The Lanier Law Firm, has been named to Law360’s Rising Stars... Read more.
CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds GeneDx (WGS) Investors of Securities Class Action Lawsuit Deadline on August 3, 2026
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In GeneDx To Contact Him Directly To Discuss... Read more.
CWCI Finds CT Claims’ Share of California Workers’ Comp Nearly Doubled from 2018-2025
OAKLAND, Calif.–(BUSINESS WIRE)–#CT–The share of California’s workers’ compensation claims identified as cumulative traumas (CT) nearly doubled... Read more.
Ci Design, Inc. Expands Internationally with New London Office
LONDON–(BUSINESS WIRE)–#Architecture–Ci Design, Inc. is expanding its international presence with the opening of a new office in the heart of London.... Read more.
Tredegar Plans to Release Second Quarter 2026 Financial Results on August 7, 2026
RICHMOND, Va.–(BUSINESS WIRE)–Tredegar Corporation (NYSE:TG) plans to release financial results for the second quarter of 2026 on August 7, 2026. About... Read more.
CORRECTING and REPLACING Lōkahi Therapeutics™ ai² Futures Lab™ Changes How Biopharma Builds a Pipeline
Futures Lab identified 45+ therapeutic opportunities on a $33,000 budget, expands to 13 university partners with 100% retention, and uncovers assets representing... Read more.
Conduent Appoints Anna Novoseletsky as Executive Vice President, General Counsel and Secretary
FLORHAM PARK, N.J.–(BUSINESS WIRE)–Conduent Incorporated (Nasdaq: CNDT), a global technology-driven business solutions and services company, today announced... Read more.
Twist Bioscience Announces Fiscal 2026 Third Quarter Financial Results
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced... Read more.
Biocon Announces U.S. Commercial Launch of Yesafili™, a Biosimilar to Regeneron’s Eylea® 2 mg
Yesafili™ (aflibercept-jbvf) now available in the United States as an U.S. FDA-approved interchangeable biosimilar to EYLEA 2 mg Potential benefit to the ~20 million... Read more.